← FDA Drug Approvals (Drugs@FDA)

MAYZENT

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2019-03-26

Drug application

FDA Application #

NDA209884

Application type

New Drug Application

Brand name

MAYZENT

Generic name

SIPONIMOD

Active ingredients

SIPONIMOD

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NOVARTIS

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2019-03-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown